Pages that link to "Item:Q5122424"
From MaRDI portal
The following pages link to Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements (Q5122424):
Displaying 11 items.
- Using earlier measures in a longitudinal sequence as a potential surrogate for a later one (Q962388) (← links)
- Center-within-trial versus trial-level evaluation of surrogate endpoints (Q1623614) (← links)
- Simplified modeling strategies for surrogate validation with multivariate failure-time data (Q2445595) (← links)
- The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials (Q2475730) (← links)
- Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling (Q3119801) (← links)
- Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach (Q3445321) (← links)
- Investigation of the correlation of successive earthquakes preceding main shocks in the Greek territory (Q5044662) (← links)
- Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes (Q5121917) (← links)
- Confidence intervals and statistical power of the ``Validation'' ratio for surrogate or intermediate endpoints (Q5939496) (← links)
- Evaluating multiple surrogate markers with censored data (Q6055488) (← links)
- Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy (Q6055756) (← links)
